FTC Case Closed: Why g-defy Shoes Still Lead in Pain Relief & Comfort
G-defy shoes by Gravity Defyer Medical Technology, the renowned innovator of high-quality, pain-relieving footwear, has emerged victorious in its hard-fought legal battle with the Federal Trade Commission (FTC). The FTC, a U.S. government agency dedicated to protecting consumers from deceptive and anticompetitive practices, rigorously enforces standards across industries to ensure fair marketplace practices. That fact that g-defy shoes has prevailed in a case brought by such a formidable regulatory body speaks volumes about the strength and credibility of its claims.
Several years ago, Gravity Defyer Medical Technology, Inc. commissioned a randomized, controlled clinical study at Olive View-UCLA Medical Center to assess a revolutionary shoe sole engineered to absorb shock. The study demonstrated statistically significant and clinically meaningful reductions in knee, back, ankle, and foot pain and was subsequently published in the peer-reviewed Journal of the American Podiatric Medical Association. Despite the FTC’s challenge—questioning the study’s design and scale—Gravity Defyer stood its ground, engaging in three years of regulatory investigation followed by three years of litigation.
The outcome is nothing short of remarkable. While the FTC maintains restrictions on referencing the clinical study in advertising, it has conceded that g-defy shoes indeed relieve pain caused by the pressure and shock of weight-bearing activities such as walking, running, and prolonged standing.
“This resolution reaffirms the credibility of our claims and the integrity of our brand,” stated Alexander Elnekaveh, founder of Gravity Defyer. “Our mission has always been to improve the lives of our customers with innovations that empower movement and relieve pain, and today’s decision reinforces that commitment.”
For Newsmax subscribers, this victory is not just legal news—it is a powerful affirmation of Gravity Defyer’s promise to deliver proven, science-backed relief. As the FTC plays a critical role in safeguarding consumers, Gravity Defyer’s success against such a rigorous opponent highlights the unmatched quality and effectiveness of its products.
G-Defy’s patented VersoShock® Technology relieves pain from running, walking, and prolonged standing. This innovative shock-absorption system is designed to correct body alignment, improve biomechanics, absorb shock, and enhance your gait.
Drawing inspiration from biomechanics and natural shock absorption mechanisms in the body, Elenekevah engineered a multi-compression spring system within the sole of the shoe to minimize impact forces while redistributing energy efficiently. After years of research and refinement, VersoShock® emerged as a groundbreaking technology that transforms footwear, delivering unparalleled comfort and pain relief for those who spend long hours on their feet.
Founded in 2006 by Alexander Elnekaveh, g‑defy by Gravity Defyer Medical Corporation began as a personal mission to relieve his nephew’s Achilles pain, leading to the creation of our patented VersoShock® Technology. When his son, recovering from a traumatic brain injury, found relief in g‑defy shoes as he learned to walk again, Alexander’s dedication to life-changing footwear was further solidified.
___________________________________________________________________________
Discover the difference that award-winning, innovative footwear can make in your life. Explore g-defy’s groundbreaking range of products that combine cutting-edge technology with unparalleled comfort and support.
Text MAX30 to 918888 to receive 30% off orders over $120 or visit g-defy.com and use code MAX30.
Explore g-defy’s groundbreaking range of products that combine cutting-edge technology with unparalleled comfort and support.
For more details, please read the full press release on the g-defy website or contact their customer service team.
